+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Galantamine"

Alzheimer's Drugs Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 93 Pages
  • Global
From
From
Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
From
From
From
Alzheimer's Therapeutics Market Report 2022-2032 - Product Thumbnail Image

Alzheimer's Therapeutics Market Report 2022-2032

  • Report
  • December 2022
  • 196 Pages
  • Global
From
From
Global Alzheimer's Treatment Market Outlook 2027 - Product Thumbnail Image

Global Alzheimer's Treatment Market Outlook 2027

  • Report
  • June 2020
  • 163 Pages
  • Global
From
From
Alzheimer's Disease Market and Forecast Analysis 2034 - Product Thumbnail Image

Alzheimer's Disease Market and Forecast Analysis 2034

  • Drug Pipelines
  • February 2019
  • 300 Pages
  • Global
From
From
Loading Indicator

Galantamine is a drug used to treat mild to moderate Alzheimer's Disease. It is an acetylcholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory, thinking, and behavior in people with Alzheimer's. Galantamine is available in both oral and intravenous forms, and is often used in combination with other Alzheimer's medications. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. Galantamine is one of several drugs used to treat Alzheimer's Disease, and is often prescribed alongside other medications such as donepezil and memantine. It is available in generic form, as well as under the brand names Razadyne and Reminyl. Companies in the Galantamine market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more